Sabin Vaccine Institute Elects Morton P. Hyman Chairman
November 24, 2008
WASHINGTON, DC – The Sabin Vaccine Institute (Sabin) today announced the election of Morton P. Hyman as its new Chairman; he joined the Board of Trustees in 2007. Mr. Hyman succeeds long-time Trustee, Chairman and founding President, Philip K. Russell, MD, who has been instrumental in positioning Sabin as an important voice in global health issues and a leader in vaccine research, development and advocacy. Mr. Hyman’s appointment is effective immediately.
“We are incredibly grateful for Dr. Russell’s many years of leadership at Sabin and I look forward to his continued contribution as a member of the Board. Mort Hyman’s election as Board Chair comes at an opportune time as we expand our activities into multi-dimensional aspects of neglected tropical and other infectious diseases. Sabin is fortunate to have the leadership of these two highly distinguished individuals, particularly as we expand our efforts in vaccine development and vaccine advocacy, and work to raise the profile of neglected tropical diseases (NTDs),” said Dr. Peter Hotez, President of Sabin Vaccine Institute and Walter G. Ross Professor and Chair of the Department of Microbiology, Immunology and Tropical Medicine at The George Washington University.
Mr. Hyman brings to Sabin extensive experience in leadership of philanthropic, business and governmental organizations. For over 30 years, he served as President and a director of Overseas Shipholding Group, a NYSE - listed company that owns and operates one of the world's largest fleet of oil tankers. He retired from the company in 2003 as Chairman of the Board and CEO. He also served as Vice Chairman of a major Swiss private bank and as President of its affiliated investment companies until his retirement in 2003, at which time he founded MPH Enterprises, LLC, a private equity investor.
Mr. Hyman noted, “I look forward to working with Sabin’s outstanding Board and staff. Their work to combat infectious diseases and to eliminate the scourge of NTDs has been remarkable. We have the opportunity to effect a meaningful and lasting change in the lives of so many forgotten people and communities. Sabin is making substantial progress through vaccine development programs in partnership with The George Washington University and through global vaccine advocacy efforts. In addition, through the Global Network for Neglected Tropical Diseases, headquartered at Sabin, we are providing proven, low-cost treatments of NTDs. In 2007 alone, members of the Global Network provided treatment for more than 147 million people for as low as 50 cents per person per year.”
Mr. Hyman’s experience in the public health arena will benefit Sabin as it builds awareness of NTDs and infectious diseases around the world. In 1971, Mr Hyman began making his mark in the public health sector with his appointment by Governor Nelson Rockefeller to the New York State Public Health Council; he served on the Council for 25 years, including 15 years as Chairman. During his tenure, the Council dealt with such issues as smoking bans in public places, nursing home regulation, Medicaid reimbursement, and access to care for AIDS patients and for the poor. In 1978, he was appointed by Governor Hugh Carey as Vice Chair of the New York State Health Planning Commission to rationalize the healthcare delivery system in New York City. He was appointed by Governor Mario Cuomo as Chair of several joint executive and legislative task forces dealing with State-wide health matters.
In 1973, Mr. Hyman joined the Board of Trustees of Beth Israel Medical Center in New York; he became Chairman in 1985 and served in that capacity for 22 years, during which time the Medical Center greatly expanded its services. In 1997, he led the formation and became the first Chair of Continuum Heath Partners, one of the largest voluntary hospital systems in the United States, which includes Beth Israel, St Luke’s, Roosevelt, New York Eye and Ear Infirmary and Long Island College Hospital; he remains on the Boards of these constituent hospitals. In 2007, Mr. Hyman was elected Chairman Emeritus of both Continuum and Beth Israel.
Mr. Hyman continues to serve on the boards of the Albert Einstein College of Medicine, the N.Y. Academy of Medicine and the N.Y. Academy of Sciences. Mr. Hyman graduated with distinction from the Cornell University Law School (1959), where he served as an Editor of the Cornell Law Review, and was elected to the Order of the Coif and Phi Kappa Phi honorary societies; he received his BA from the Cornell University School of Arts and Sciences (1956).
In recognition of his leadership, commitment and dedication, Mr. Hyman has received numerous awards, including an honorary Doctor of Humane Letters (honoris causa) from New York Medical College; 2002 Healthcare Leadership Award from the United Hospital Fund; 2001 Trustee of the Year Award from Modern Healthcare Magazine; 2002 Leadership in Business Award from the New York Business Group on Health; and the 2000 Ellis Island Medal of Honor. Mr. Hyman lives in Manhattan with his wife, Chris Stern Hyman. They have two adult children, David Hyman and Sarah Washkowitz.
About Sabin Vaccine Institute
Sabin Vaccine Institute is a non-profit organization dedicated to reducing human suffering caused by infectious and neglected diseases. Through its efforts in research, development and advocacy, Sabin works to provide greater access to vaccines and essential medicines for millions caught in the cycle of pain, poverty, and despair. Founded in 1993 in honor of Dr. Albert B. Sabin, discoverer of the oral polio vaccine, the Sabin Vaccine Institute works with prestigious institutions, scientists, medical professionals and organizations to provide short - and long-term solutions resulting in healthier individuals, families and communities around the globe. For more information please visit: www.sabin.org and www.globalnetwork.org.